Tuesday, August 12, 2014

Top 5 Heal Care Stocks To Own For 2014

Investors and analysts who are following Time Warner (NYSE: TWX  ) have likely been following the upcoming spin-off of the conglomerate's magazine�division, Time. It's a tough sell to even the most avid spin-off investor, given that the magazine industry is in complete upheaval, and many of Time's properties are struggling. But, as the market focuses and derides this pending event, there's a more intriguing story on the horizon. As growth in Time Warner's cable and studio business is softening in the United States, the company's management is looking abroad for patches of growth. Now the company is reportedly preparing a $1 billion bid for a Turkish TV network. Could this bring a big boost to Time Warner shares?

Shrinking and Expanding
Time Warner has been a busy business in recent years -- spinning�off Time Warner Cable, the broadband cable provider, as well as Internet pioneer company AOL. The remaining entity (excluding the magazines), Time Warner, is a collection of cable television properties and the movie studio Warner Brothers. The de-consolidation appears to have been a success thus far, with the company trading at its 52-week highs, and posting a two-year gain of nearly 70%.

Hot Oil Stocks For 2015: dELIA*s Inc.(DLIA)

dELiA*s, Inc. operates as a direct marketing and retail company in the United States. It offers a collection of apparel, dresses, swimwear, roomwear, footwear, outerwear, and key accessories primarily for teenage girls. The company sells its products through direct mail catalogs, Websites, and mall-based specialty retail stores under the dELiA*s brand name. As of January 29, 2011, it operated 114 dELiA*s retail stores. The company also markets and sells branded junior apparel, dresses, accessories, swimwear, footwear and outerwear primarily to young women through catalogs and Internet under the Alloy brand name. dELiA*s, Inc. was founded in 1997 and based in New York, New York.

Advisors' Opinion:
  • [By Sean Williams]

    Don't fight history
    Sometimes we just have to remember as investors that there isn't room enough for every company to succeed. Thus enters dELiA*s (NASDAQ: DLIA  ) , an online and mail catalog retailer that markets apparel to teenage girls and young women.

  • [By Eric Volkman]

    dELIA*s (NASDAQ: DLIA  ) is now a lighter company following the divestment of one of its brand lines. The company announced that it has sold its Alloy subsidiary to HRSH Acquisitions, which is conducting business under the name Alloy Apparel and Accessories. dELIA*s was paid $3.7 million in cash for the unit, and the buyer will assume roughly $3.1 million in liabilities.

Top 5 Heal Care Stocks To Own For 2014: Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.

GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.

Advisors' Opinion:
  • [By Roberto Pedone]

     

    Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.

     

    Monday's Volume: 674,000

    Three-Month Average Volume: 222,171

    Volume % Change: 149%

     

    Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.

     

     

    From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.

     

    Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.

     

Top 5 Heal Care Stocks To Own For 2014: Bison Petroleum Corp (BISN)

Bison Petroleum Corp. (Bison), incorporated on February 9, 2010, is an independent American oil and gas company founded to provide the United States energy security by developing and producing oil and gas from the nation's energy heartlands. Bison's holdings are located in the Bighorn Basin, Wyoming.

On August 9, 2013, he Company entered into a Lease Purchase Agreement with Nelan Advisors Corporation (Nelan), whereby Nelan sold certain oil and gas leases issued by the State of Wyoming to Bison. Bison focuses to commence oil and gas drilling operations on these leases.

Advisors' Opinion:
  • [By Peter Graham]

    On Friday, small cap stocks Bison Petroleum Corp (OTCMKTS: BISN) and Interactive Leisure Systems Inc (OTCMKTS: IALS) sank 16.27% and 16%, respectively, and despite being the subject of recent paid promotions or investor relation campaigns. Of course, there is nothing wrong with a properly disclosed stock promotion or paid for investor relations campaigns, but investors and traders alike need to be careful about how they get into and exit such stocks before getting badly burned. With that in mind, here is a quick look at both small cap stocks to help you decide on an investment or trading strategy for this week:

    Bison Petroleum Corp (OTCMKTS: BISN) Has Given Another Corporate Update

    Small cap Bison Petroleum Corp is a publicly traded oil and gas exploration and development company based in Salt Lake City, Utah, and dedicated to the exploration and development of domestic Energy in the Bighorn Basin of Wyoming. On Friday, Bison Petroleum Corp sank 16.27% to $1.39 for a market cap of $65.35 million plus BISN is up 396.4% since last June according to Google Finance.

Top 5 Heal Care Stocks To Own For 2014: ICL Israel Chemicals Ltd (ICL)

ICL Israel Chemicals Ltd (ICL) is an Israel-based company, engaged in the fertilizer and specialty chemical sectors. The company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from three sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus; elemental bromine, and other chemicals. In addition the Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals. Advisors' Opinion:
  • [By Claudia Maedler]

    In Israel, the TA-25 Index (TA-25) gained 1.9 percent at the close in Tel Aviv as Israel Corp. jumped 9 percent, the most since July 2009, to 1,755 shekels. The shares soared along with those of its Israel Chemicals Ltd. (ICL) unit, which advanced 6.4 percent on speculation that a possible change in ownership of Russian potash producer OAO Uralkali could help stabilize prices of the crop nutrient.

  • [By Gwen Ackerman]

    Israel Chemicals Ltd. (ICL), the fourth-largest potash producer in the world by sales, is weighing on the Tel Aviv benchmark stock index on concern the government will exact higher royalties amid a global oversupply.

No comments:

Post a Comment